From: Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy
Population | Total samples | HERV-K113+ (%) | HERV-K115+ (%) | HERV-K113+ (%) |
---|---|---|---|---|
VBD | 30 | 2(7) | 6(20) | 8(27) |
LGLL | 3 | 1(33) | 0(0) | 1(33) |
HTVLt | 24 | 0(0) | 4(17) | 4(17) |
HTVLm | 13 | 0(0) | 1(8) | 1(8) |
HTVLn | 11 | 0(0) | 3(27) | 3(27) |
MS | 24 | 4(17) | 4(17) | 8(33) |